Compare SOTK & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOTK | ALPS |
|---|---|---|
| Founded | 1975 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.1M | 66.6M |
| IPO Year | 1995 | 2024 |
| Metric | SOTK | ALPS |
|---|---|---|
| Price | $5.78 | $0.39 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 44.3K | ★ 60.1K |
| Earning Date | 10-13-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $20,909,315.00 | N/A |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $10.38 | N/A |
| P/E Ratio | $115.80 | ★ N/A |
| Revenue Growth | ★ 1.97 | N/A |
| 52 Week Low | $3.40 | $0.23 |
| 52 Week High | $6.24 | $1.72 |
| Indicator | SOTK | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 69.22 | 50.35 |
| Support Level | $4.59 | $0.38 |
| Resistance Level | $6.24 | $0.44 |
| Average True Range (ATR) | 0.33 | 0.02 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 86.92 | 47.47 |
Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.